13F Holdings
中文EN

JUSH Jushi Holdings Inc.

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1909747 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.2%
TTM net income YoY15.7%
TTM EPS YoY15.2%
Revenue 3-yr CAGR-0.2%
Net income 3-yr CAGR—

Margins

Gross margin44.2%
Operating margin2.4%
Net margin-20.0%
FCF margin2.2%
EBITDA margin11.1%

Returns

ROE—
ROA-12.9%
ROIC (approx.)8.6%
Asset turnover0.65x

Leverage & solvency

Liabilities / assets136.3%
Debt / equity—
Current ratio0.79x
Interest coverage0.16x

Cash quality & payout

Operating cash flow / net income-0.34x
Accruals ratio-17.3%
Payout ratio—
Capex / revenue4.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$262.91M$257.52M$269.44M$284.28M$209.29M
Cost of revenue$148.93M$139.22M$153.22M$188.81M$125.90M
Gross profit$113.98M$118.30M$116.23M$95.48M$83.39M
SG&A expense$109.13M$107.01M$110.47M$156.17M$112.81M
Operating income$4.85M$10.86M-$2.82M-$220.33M-$35.77M
Interest expense$41.30M$37.98M$37.06M$45.73M$30.85M
Income tax$34.99M$31.63M$31.81M$8.45M$29.62M
Net income-$68.59M-$48.78M-$65.10M-$202.32M$20.25M
EBITDA$35.84M$40.75M$23.77M-$193.84M-$27.35M
EPS (basic)-0.35-0.25-0.33-1.060.12
EPS (diluted)-0.35-0.25-0.33-1.44-0.42
Weighted avg. shares (diluted)195.20M195.16M194.77M204.24M201.61M
Banking
Net interest income——-$36.97M-$45.59M-$30.61M
Balance sheet
Cash & equivalents$24.05M$21.35M$31.30M$27.15M$94.96M
Receivables$2.80M$1.46M$3.38M$4.81M$3.20M
Inventory$34.61M$36.14M$33.59M$35.09M$43.32M
Current assets$68.31M$72.15M$81.64M$70.05M$154.36M
PP&E, net$143.32M$144.06M$159.27M$177.75M$137.28M
Goodwill$30.91M$30.91M$30.91M$38.24M$45.83M
Intangibles$92.20M$100.47M$95.97M$100.08M$192.47M
Total assets$422.34M$440.32M$463.39M$529.34M$652.05M
Current liabilities$66.19M$68.89M$162.46M$107.63M$83.93M
Short-term debt$6.64M$2.76M$86.51M$8.70M$6.18M
Long-term debt$199.19M$183.45M$126.04M$180.56M$119.80M
Total debt$205.83M$186.21M$212.56M$189.26M$125.98M
Total liabilities$537.69M$490.56M$471.01M$483.45M$471.07M
Shareholders' equity-$115.34M-$50.23M-$6.23M$47.28M$182.37M
Net debt$181.79M$164.86M$181.25M$162.12M$31.02M
Cash flow statement
Operating cash flow$17.73M$21.57M-$3.32M-$21.42M-$14.30M
Capital expenditure$16.09M$4.71M$10.74M$56.88M$75.30M
Free cash flow$1.64M$16.86M-$14.06M-$78.30M-$89.60M
Investing cash flow-$13.22M-$7.07M-$6.39M-$80.86M-$113.45M
Financing cash flow$767,000-$24.46M$13.87M$33.98M$137.66M
Depreciation & amortization$30.99M$29.89M$26.59M$26.49M$8.41M
Stock-based compensation$2.10M$4.22M$8.09M$23.07M$14.51M

Free plan shows the latest 5 periods; Pro shows all 6 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.